Records containing: Neuromyelitis Optica
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-27An Open Label Trial Evaluating the Efficacy and Safety of Bruton's Tyrosine Kinase (BTK) Inhibitor Zanubrutinib in Adult Patients With Neuromyelitis Optical Spectrum Disorders (NMOSDs)
-
CLINICAL_TRIALS study record update · 2026-02-27High-Dose Immunosuppressive Therapy Using Carmustine, Etoposide, Cytarabine, and Melphalan (BEAM) + Thymoglobulin Followed by Syngeneic or Autologous Hematopoietic Cell Transplantation for Patients With Autoimmune Neurologic Diseases
-
CLINICAL_TRIALS study record update · 2026-01-06Collaboration on Neuroimmunology: Question, Understand, Educate, Restore - The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders
-
CLINICAL_TRIALS study record update · 2025-10-02Large-scale, Multi-disciplinary Sample and Data Repository for Multiple Sclerosis and Related Demyelinating Diseases
-
CLINICAL_TRIALS study record update · 2025-09-08Study of Inectolizumab Combined With Steroid Hormone Adjustment Strategies in Treatment-naive Patients With Neuromyelitis Optica Spectrum Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-08-11A Study on the Safety and Efficacy of Chimeric Antigen Receptor T Cells in the Treatment of Recurrent/Refractory Neuromyelitis Optica
-
CLINICAL_TRIALS study record update · 2025-08-05Clinical and Radiological Outcomes in People With Aquaporin-4 IgG Positive Neuromyelitis Optica Spectrum Disorder Treated With Ravulizumab
-
CLINICAL_TRIALS study record update · 2025-06-18Longitudinal Investigation of Cortical Demyelination and Meningeal Inflammation in Multiple Sclerosis and Related Disorders
-
CLINICAL_TRIALS study record update · 2025-04-30High Frequency Impulse Therapy for Neuropathic Pain in NMOSD
-
CLINICAL_TRIALS study record update · 2025-04-10Performance and Safety of a Digital Tool for Unsupervised Self-assessment of Neuromyelitis Optica Spectrum Disorder
-
CLINICAL_TRIALS study record update · 2025-03-30A Multi-center, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders (NMOSD)
-
CLINICAL_TRIALS study record update · 2024-09-25A Phase 2/3 Open-Label, Single-Arm Trial to Evaluate the Safety and Activity of Eculizumab in Pediatric Patients With Relapsing Neuromyelitis Optica Spectrum Disorder
-
CLINICAL_TRIALS study record update · 2024-07-11FcRn Antagonists (Efgartigimod) for Acute Neuromyelitis Optica Spectrum Disorders (NMOSD) Attack: a Phase 2, Randomized Controlled Trial.
-
CLINICAL_TRIALS study record update · 2024-06-21IMCY-NMO-000 In Vitro Study of the Biological and Immunological Activity of Imotopes® Candidates on Blood Cells of Patients With Stabilized Neuromyelitis Optica (PHASE 0)
-
CLINICAL_TRIALS study record update · 2024-04-11Single-center, Open Label Trial of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active Neuromyelitis Optica Spectrum Disorders (NMOSD)
-
CLINICAL_TRIALS study record update · 2024-04-10Pediatric Neuromyelitis Optica Spectrum Disorder (NMOSD) 1 Year Observational Study
-
CLINICAL_TRIALS study record update · 2023-11-07Effectiveness and Safety of Efgartigimod in the Acute Phase of Neuromyelitis Optica Spectrum Disorders-a Multicentric, Controlled, Retrospective, Real-Word Study
-
CLINICAL_TRIALS study record update · 2023-09-05PEDIATRIC SONICS: Pediatric Study of Neuropsychology and Imaging in CNS Demyelinating Syndromes.
-
CLINICAL_TRIALS study record update · 2023-08-09A Phase 3, External Placebo-Controlled, Open-Label, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD)
-
CLINICAL_TRIALS study record update · 2023-06-07An Open Label, add-on Trial of Cetirizine for Patients With Neuromyelitis Optica
-
CLINICAL_TRIALS study record update · 2022-11-14MS and NMOSD in African-Americans: a Prospective Data Collection Protocol Using REDCap
-
CLINICAL_TRIALS study record update · 2022-10-10Determination of the Frequency of Restless Legs Syndrome and Associated Factors in People With Neuromyelitis Optica Spectrum Disorder
-
CLINICAL_TRIALS study record update · 2022-08-23A Phase III, Open-label, Extension Trial of ECU-NMO-301 to Evaluate the Safety and Efficacy of Eculizumab in Patients With Relapsing Neuromyelitis Optica (NMO)
-
CLINICAL_TRIALS study record update · 2022-02-24Optic Neuritis Differential Diagnosis Study (ONDDS)
-
CLINICAL_TRIALS study record update · 2022-02-17Effects of Ozanimod on Immune-mediated Mechanisms of Neurodegeneration in Multiple Sclerosis - a Preclinical Study